How Can We Improve Patient Centricity In Benefit-Risk Assessments? Posted on August 25, 2022September 13, 2022 by Hannah Faulkner How Can We Improve Patient Centricity In Benefit-Risk Assessments?
How Technology Can Bring New, Diverse Investigators Into Clinical Trials Right Now Posted on July 25, 2022July 27, 2022 by Hannah Faulkner How Technology Can Bring New, Diverse Investigators Into Clinical Trials Right Now
Tufts Study Provides ‘First Hard Metrics’ Around Decentralized Clinical Trials Posted on July 13, 2022 by Hannah Faulkner Tufts Study Provides ‘First Hard Metrics’ Around Decentralized Clinical Trials
Digital Tools Driving Innovative Clinical Trials Posted on July 8, 2022July 25, 2022 by Hannah Faulkner Digital Tools Driving Innovative Clinical Trials
Free the Clinical Trial Posted on July 7, 2022July 11, 2022 by Hannah Faulkner Free the Clinical Trial
Clinical Trial Upgrades Will Open Care Up to More People Posted on May 26, 2022June 3, 2022 by Hannah Faulkner Clinical Trial Upgrades Will Open Care Up to More People
The Push for Clinical Trials 2.0 Posted on May 4, 2022May 4, 2022 by Hannah Faulkner The Push for Clinical Trials 2.0
From Subject to Partner: The Evolving Relationship Between Patients and Clinical Research Posted on April 22, 2022May 13, 2022 by Hannah Faulkner From Subject to Partner: The Evolving Relationship Between Patients and Clinical Research
World Parkinson’s Day 2022 – A patient centred model for Parkinson’s research Posted on April 11, 2022April 15, 2022 by Hannah Faulkner World Parkinson’s Day 2022 – A patient centred model for Parkinson’s research
Covid-19 Two Years On: Persistent Symptoms of Clinical Trial Disruption Trouble Certain Therapy Areas Posted on April 4, 2022 by Hannah Faulkner Covid-19 Two Years On: Persistent Symptoms of Clinical Trial Disruption Trouble Certain Therapy Areas
